TITLE

Continued shortage for Hib vaccine

AUTHOR(S)
Elliott, William T.
PUB. DATE
January 2009
SOURCE
Travel Medicine Advisor;Jan2009 Supplement, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the impact of the continued shortage of the Haemophilus influenza type b (Hib) vaccine on public health. According to "Morbidity and Mortality Weekly Report" (MMWR), a shortage in the vaccine did not lead to an increase in Haemophilus infections. A year ago, the U.S. Centers for Disease Control and Prevention (CDC) recommended deferring the fourth dose of the vaccine in healthy children because of a shortage due to contamination concerns in the manufacturing process. Now it is recommending vigilance on the part of pediatricians.
ACCESSION #
35903675

 

Related Articles

  • CDC calls for better management of VFC vaccine supplies. Richards, Cassandra A. // Infectious Diseases in Children;Jul2012, Vol. 25 Issue 7, p24 

    The article informs that the U.S. Centers for Disease Control and Prevention (CDC) has announced that the agency and its partners are working with a sense of urgency for better management of Vaccines for Children (VFC) program vaccine supplies.

  • CDC issues new vaccine recommendations.  // Alternative Medicine Alert;Nov2009 Pharmacology Watch Supp, p1 

    The article highlights the changes made by the U.S. Centers for Disease Control and Prevention on its vaccine recommendations. The Advisory Committee on Immunization Practices (ACIP) suggests the revaccination of people who are at prolonged increased risk for meningococcaI disease. The...

  • Continued shortage for Hib vaccine. Elliott, William T. // Clinical Cardiology Alert;Jan2009 Pharmacology, p2 

    The article reports that despite of the continued shortage of the Haemophilus influenza type b (Hib) vaccine, Haemophilus infections did not increase in the U.S., according to the "Morbidity and Mortality Weekly Report." It presents the findings of a national surveillance conducted by the...

  • CDC Increases Influenza Surveillance, Reaffirms Interim Vaccination Guidelines.  // American Family Physician;1/15/2009, Vol. 79 Issue 2, p92 

    The article reports on the efforts of the U.S. Centers for Disease Control and Prevention (CDC) to increase its surveillance for Haemophilus influenzae type b (Hib) disease. It notes that the decision to heighten surveillance resulted from the continued shortage of the Hib conjugate vaccine. It...

  • Continued shortage for Hib vaccine.  // Clinical Oncology Alert;Jan2009 Pharmacology Watch, p2 

    The article reports on the impact of the continued shortage of the Haemophilus influenza type B (Hib) vaccine on the number of Haemophilus infections in the U.S. According to the "Morbidity and Mortality Weekly Report" (MMWR), shortage in the vaccine did not lead to an increase in infections....

  • CDC issues new vaccine recommendations. Elliott, William T. // Primary Care Reports;Nov2009 Pharmacology Watch, p1 

    The article outlines the new vaccine recommendations of the Centers for Disease Control and Prevention (CDC) of the U.S. A booster with the quadravalent meningococcal conjugate is recommended by the Advisory Committee on Immunization Practices (ACIP) for individuals with increased susceptibility...

  • CDC issues new vaccine recommendations. Elliott, William T. // Infectious Disease Alert;Nov2009 Infectious D, p1 

    The article reports on revisions made by the U.S. Centers for Disease Control and Prevention (CDC) on its vaccine recommendations. According to the Advisory Committee on Immunization Practices (ACIP), revaccination is advised for persons at prolonged increased risk for meningococcal disease....

  • The Ups and Downs of Hib Immunizations.  // Pediatrics for Parents;2008, Vol. 24 Issue 12, p13 

    The article reports on the shortage of the vaccine to Haemophilus influenzae type b (Hib) in the U.S. It states that the shortage is due to problems in manufacturing. It mentions that the Centers for Disease Control and Prevention (CDC) has recommended the delay of Hib booster due to its...

  • Hib vaccine lots recalled.  // Infectious Diseases in Children;Jan2008, Vol. 21 Issue 1, p1 

    The article reports that 11 lots of Haemophilus influenzae type b vaccine and two lots of combination Haemophilus influenzae type b/hepatitis B vaccine from Merck were recalled for sterility test. Officials have not found contamination in Hib conjugate (PedvaxHIB) and Hib combination (Comvax)...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics